We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

25 hedge funds and large institutions have $17.5M invested in Zosano Pharma Corporation in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

22% less funds holding

Funds holding: 32 → 25 (-7)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

38% less capital invested

Capital invested by funds: $28.5M → $17.5M (-$11M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
25
Holders Change
-7
Holders Change %
-21.88%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
9
Reduced
2
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.15M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$791K
3
Morgan Stanley
Morgan Stanley
New York
+$598K
4
TI
Telemetry Investments
New York
+$405K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$328K

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$2.27M
2
CH
CVI Holdings
Delaware
-$1.89M
3
HRCM
Hawk Ridge Capital Management
California
-$1.01M
4
SCM
Stonepine Capital Management
Oregon
-$1.01M
5
GPCM
Granite Point Capital Management
Massachusetts
-$504K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
– -$1.89M -10,703 Closed
HRCM
27
Hawk Ridge Capital Management
California
– -$1.01M -5,714 Closed
SCM
28
Stonepine Capital Management
Oregon
– -$1.01M -5,714 Closed
GPCM
29
Granite Point Capital Management
Massachusetts
– -$504K -2,857 Closed
OM
30
Opaleye Management
Massachusetts
– -$504K -2,857 Closed
Verition Fund Management
31
Verition Fund Management
Connecticut
– -$504K -2,857 Closed
Squarepoint
32
Squarepoint
New York
– -$445K -2,524 Closed
TAM
33
Tiverton Asset Management
Delaware
– -$403K -2,286 Closed
FCM
34
Flinton Capital Management
Pennsylvania
– -$206K -1,166 Closed
TAM
35
Tyers Asset Management
Texas
– -$169K -960 Closed
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
– -$139K -786 Closed
NA
37
Neuburgh Advisers
California
– -$133K -754 Closed
MCIM
38
Meadow Creek Investment Management
Georgia
– -$97K -549 Closed
HighTower Advisors
39
HighTower Advisors
Illinois
– -$58K -329 Closed
UBS Group
40
UBS Group
Switzerland
– -$1K -7 Closed
FHA
41
Flagship Harbor Advisors
Massachusetts
– +$452 +3 New
1
2

ZSAN Hedge Fund Activity: Q2 2018 in Review

25 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2018, worth a combined $17.5M — down 38% from $28.5M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ZSAN and 10 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 9 added.

The largest buyer was Sabby Management, adding an estimated $1.15M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $2.27M sold.

  • 25 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2018, down from 32 in Q1 2018.
  • Funds reported $17.5M of Zosano Pharma Corporation stock for Q2 2018, down 38% quarter-over-quarter.
  • 10 funds opened new Zosano Pharma Corporation positions in Q2 2018 and 16 closed out, a net change of -6 holders.
  • The largest Zosano Pharma Corporation buyer in Q2 2018 was Sabby Management, an estimated $1.15M added.
  • The largest Zosano Pharma Corporation seller in Q2 2018 was Monashee Investment Management, an estimated $2.27M sold.

Based on aggregated 13F filings for Q2 2018.